Spring Bank Pharmaceuticals Announces the Data Safety Monitoring Board Approves Dose Escalation of SB 9200 for the Second Cohort of the Phase 2a Segment of the ACHIEVE Trial, a Global Phase 2 Clinical Trial for Chronic Hepatitis B Virus (HBV)
May 15, 2017 08:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., May 15, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals to Present at the East Coast IDEAS Investor Conference on May 18th in Boston
May 01, 2017 08:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., May 01, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals (NASDAQ:SBPH) today announced that Martin Driscoll, president and chief executive officer of Spring Bank...
Spring Bank Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 Financial and Operational Results
April 28, 2017 08:30 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., April 28, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals to Present Results from In Vivo Studies of SB 11285, a Novel STING agonist for Immuno-Oncology, at Keystone Symposia
February 21, 2017 08:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Feb. 21, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc., (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Provides Corporate Update and Reports 2016 Financial and Operational Results
February 15, 2017 08:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals to Present at the 19th Annual BIO CEO & Investor Conference in NYC
February 06, 2017 10:11 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Garrett Winslow Joins Spring Bank as Vice President of Legal
January 04, 2017 09:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Jan. 04, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank and Arbutus Biopharma Announce Preclinical Collaboration in Study of Chronic Hepatitis B
December 19, 2016 07:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
Spring Bank Pharmaceuticals Announces Financing of $15 Million
November 18, 2016 08:58 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Nov. 18, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment...
Spring Bank Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2016 Financial Results
October 31, 2016 07:00 ET
|
Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...